In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Company facts
| Company | Danaher Corporation |
|---|---|
| Symbol | DHR |
| Exchange | XNYS |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market cap | $140.97B (Massive market data, 2026-09-10) |
| Employees | 60,000 |
| Country | United States |
| Website | https://www.danaher.com |
Trading — Danaher Corporation
| Last price | $200.14 |
|---|---|
| Change | -0.19% |
| Previous close | $200.53 |
| Day range | $199.16 – $202.66 |
| 50-day average | $202.05 |
| 200-day average | $202.64 |
| Average volume | 4,301,962 |
Price basis: yfinance_daily_bar_close · 2026-09-11T20:31:40.505291+00:00
Valuation and financial health
| Earnings per share | $6.75 |
|---|---|
| Price / book | 2.64 |
| Price / cash flow | 19.68 |
| Enterprise value / EBITDA | 22.54 |
| Enterprise value / sales | 6.43 |
| Debt / equity | 0.34 |
| Current ratio | 1.68 |
| Dividend yield | 0.58% |
| Free cash flow | $5.78B |
| Cash ratio | 0.71 |
| Enterprise value | $153.51B |
Reported 2026-09-10
Earnings
| Report date | 2026-10-20 |
|---|---|
| Session | Pre Market |
| Fiscal quarter ending | Sep/2026 |
| EPS estimate | $1.96 |
| Year-ago EPS | $1.89 |
| Analyst estimates | 9 |
Source: Nasdaq.com public earnings calendar
Other Healthcare companies
Live data
Live quotes, options positioning, insider and congressional filings for DHR are on the IntelTrends dashboard.